Revenue £m

+6.3% at £12.9m

2012 10.9
2013 12.1
2014 12.9

show raw data

Underlying* operating profit £m

+4.4% at £2.8m

2012 2.3
2013 2.7
2014 2.8

show raw data

Underlying* basic EPS pence

+2.9% at 10.8p

2012 9.3
2013 10.5
2014 10.8

show raw data

Financial Highlights

Underlying* EBITDA£3.2m£2.9m£2.5m
Underlying* operating profit£2.8m£2.7m£2.3m
Profit for the year£2.1m£1.9m£1.7m
Basic underlying* earnings per share10.8p10.5p9.3p
Dividend per share5.5p5.3p4.5p
Cash and cash equivalents£3.8m£3.7m£2.3m

* Underlying measures are before the effect of exceptional costs and other items. These are analysed in note 4.

Operational Highlights

  • Strong revenue growth from our Licensed Veterinary Medicines group, up 9.5% to £7.9m (2013: £7.2m)
  • Companion Animal Identification group sales and marketing strategy started to deliver with revenue growth of 7.8% to £2.4m (2013: £2.2m)
  • Animal welfare products has seen top line decline, with margin improvement in line with management intention to streamline lower value products
  • Three new products launched in the year
  • Investment in infrastructure and senior management team to position ourselves for future growth
  • IT investment creating a more robust infrastructure to business and Identichip database